CClinicalTrials.gg
Sign In
Status unknownNCT03705455ISAPUpdated Oct 15, 2018

Immunization Schedule Alert Platform

An interventional study of ISAP SMS in Immunization, sponsored by Lifespan Healthcare Resource Limited. Status unknown at 1 site in Nigeria. Open to participants aged 6 Weeks to 12 Months, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-10-15.

Sponsored by Lifespan Healthcare Resource Limited · Not applicable, Interventional, and Prevention

The sponsor has not verified this record recently (last verified Oct 2018), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
1,800
Allocation
Randomized
Ages
6 Weeks to 12 Months
Sex
All
01

Study summary

The ISAP study is investigating the efficacy of SMS messages in improving routine childhood Immunization timeliness and completeness in Nigeria.

Read the detailed description

The ISAP - Immunization Schedule Alert Platform study is investigating the efficacy of ISAP SMS exposure to Caregivers with children( who have fulfilled our inclusion criteria) due for routine childhood Immunisation in influencing decision for timely and complete Immunization uptake. ISAP SMS messages contains information on the Immunization appointment schedule, time ,vaccine to be administered and the address of the Immunization centre.

02

Conditions studied

  • Immunization
03

In context

Lead sponsor

Lifespan Healthcare Resource Limited is the lead sponsor of 3 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Weeks to 12 Months
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Inclusion Criteria:

Caregiver with child due for birth dose vaccination or at 6weeks-OPV1,Penta1,PCV1,Rota1.

Exclusion Criteria: Caregiver with child who have already had OPV1,Penta1,PCV1and Rota1.

-

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
1,800 participants (estimated)

Study arms

  • Active comparator
    ISAP SMS

    ISAP SMS will be sent to enrolled caregivers

    Behavioral: ISAP SMS

  • No intervention
    No ISAP SMS

    No ISAP SMS will be sent to enrolled caregivers

Interventions

  • BehavioralISAP SMS

    ISAP SMS is a text message for caregivers use that provides immunization schedule and vaccine availability at the nearest immunization clinic.

06

What researchers measure

Primary outcomes

  1. Proportion of timely and complete vaccine uptake after ISAP SMS Intervention

    Proportion of timely and complete vaccine uptake after ISAP SMS Intervention

    Time frame: 12 months

07

Study locations

1 site
  • Nkanu East Health centre Immunization clinic
    Enugu, Nigeria
08

References and documents

Publications

  • Palmer MJ, Henschke N, Bergman H, Villanueva G, Maayan N, Tamrat T, Mehl GL, Glenton C, Lewin S, Fonhus MS, Free C. Targeted client communication via mobile devices for improving maternal, neonatal, and child health. Cochrane Database Syst Rev. 2020 Jul 14;8(8):CD013679. doi: 10.1002/14651858.CD013679. PubMed 32813276 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 15, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03705455
Lead sponsor
Lifespan Healthcare Resource Limited
Responsible party
Dr.Ihedioha Emmanuel Chukwunwike (Principal Investigator, Lifespan Healthcare Resource Limited) — Principal investigator
First posted
Oct 15, 2018
Start date
Nov 1, 2018 (estimated)
Primary completion
Dec 31, 2019 (estimated)
Completion
Dec 31, 2019 (estimated)
Last update
Oct 15, 2018

Study contacts

Emmanuel Ihedioha, MBBS
Contact
emmanuel.ihedioha@lifespanhcr.com
23407038861841 ext. 23407038861841
Emmanuel Ihedioha, MBBS
principal investigator · Lifespan Healthcare Resource

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Oct 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies from this sponsor

Lifespan Healthcare Resource Limited

Start the discussion